Prothena Corp PLC Sustainability Reports
Prothena Corporation PLC specializes in the development of novel therapies for neurodegenerative diseases through the discovery and development of monoclonal antibodies.
Sector: Health Care
Country: Ireland
Exchange: Nasdaq Stock Market
ISIN: IE00B91XRN20
10 reports from 2014 to 2024
- Prothena Corp PLC 2024 Directors’ Report and Consolidated Financial Statements
- Prothena Corp PLC 2023 Directors’ Report and Consolidated Financial Statements
- Prothena Corp PLC 2022 Directors' Report and Consolidated Financial Statements
- Prothena Corp PLC 2021 Directors’ Report and Consolidated Financial Statements
- Prothena Corp PLC 2020 Annual Report
Company Profile
Prothena Corp PLC
Prothena Corporation PLC specializes in the development of novel therapies for neurodegenerative diseases through the discovery and development of monoclonal antibodies.
Reports